These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 38988926)
1. The prognostic value of immune escape-related genes in lung adenocarcinoma. Jia HR; Li WC; Wu L Transl Cancer Res; 2024 Jun; 13(6):2647-2661. PubMed ID: 38988926 [TBL] [Abstract][Full Text] [Related]
2. Bioinformatics analysis of an immunotherapy responsiveness-related gene signature in predicting lung adenocarcinoma prognosis. Jiang Y; Hammad B; Huang H; Zhang C; Xiao B; Liu L; Liu Q; Liang H; Zhao Z; Gao Y Transl Lung Cancer Res; 2024 Jun; 13(6):1277-1295. PubMed ID: 38973963 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of cancer-associated fibroblasts-related genes in lung adenocarcinoma. Li W; Shi S Transl Cancer Res; 2023 Aug; 12(8):1895-1911. PubMed ID: 37701101 [TBL] [Abstract][Full Text] [Related]
4. Construction and validation of a prognostic model for stemness-related genes in lung adenocarcinoma. Zhang H; Cao C; Xiong H Transl Cancer Res; 2024 Mar; 13(3):1351-1366. PubMed ID: 38617509 [TBL] [Abstract][Full Text] [Related]
5. Leveraging diverse cell-death patterns to predict the clinical outcome of immune checkpoint therapy in lung adenocarcinoma: Based on muti-omics analysis and vitro assay. Liang H; Li Y; Qu Y; Zhang L Oncol Res; 2023; 32(2):393-407. PubMed ID: 38186574 [TBL] [Abstract][Full Text] [Related]
6. Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches. Jiang J; Zhang Y; Wang J; Yang X; Ren X; Huang H; Wang J; Lu J; Zhong Y; Lin Z; Lin X; Jia Y; Lin S PeerJ; 2023; 11():e16166. PubMed ID: 37790630 [TBL] [Abstract][Full Text] [Related]
7. Histone acetylation modification regulator-mediated tumor microenvironment infiltration characteristics and prognostic model of lung adenocarcinoma patients. Wang W; Shen Y; Zhang P; Liu L; Sha X; Li H; Wang S; Zhang H; Zhou Y; Shi J J Thorac Dis; 2022 Oct; 14(10):3886-3902. PubMed ID: 36389327 [TBL] [Abstract][Full Text] [Related]
8. Development of a copper metabolism-related gene signature in lung adenocarcinoma. Chang W; Li H; Zhong L; Zhu T; Chang Z; Ou W; Wang S Front Immunol; 2022; 13():1040668. PubMed ID: 36524120 [TBL] [Abstract][Full Text] [Related]
9. Development of a novel embryonic germline gene-related prognostic model of lung adenocarcinoma. Liu L; Xu K; Zhou Y PeerJ; 2021; 9():e12257. PubMed ID: 34721973 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis to identify a novel diagnostic marker of lung adenocarcinoma and its immune infiltration landscape. Zhu A; Pei D; Zong Y; Fan Y; Wei S; Xing Z; Song S; Wang X; Gao X Front Oncol; 2023; 13():1199608. PubMed ID: 37409245 [TBL] [Abstract][Full Text] [Related]
11. Development and validation of polyamines metabolism-associated gene signatures to predict prognosis and immunotherapy response in lung adenocarcinoma. Wang N; Chai M; Zhu L; Liu J; Yu C; Huang X Front Immunol; 2023; 14():1070953. PubMed ID: 37334367 [TBL] [Abstract][Full Text] [Related]
12. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma. Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203 [TBL] [Abstract][Full Text] [Related]
13. Construction and validation of a prognostic model for lung adenocarcinoma based on endoplasmic reticulum stress-related genes. Li F; Niu Y; Zhao W; Yan C; Qi Y Sci Rep; 2022 Nov; 12(1):19857. PubMed ID: 36400857 [TBL] [Abstract][Full Text] [Related]
14. Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis. Zhu M; Zeng Q; Fan T; Lei Y; Wang F; Zheng S; Wang X; Zeng H; Tan F; Sun N; Xue Q; He J Front Immunol; 2022; 13():783495. PubMed ID: 35222371 [TBL] [Abstract][Full Text] [Related]
15. Prognosis and immunotherapy significances of a cancer-associated fibroblasts-related gene signature in lung adenocarcinoma. Luo Y; Zhang S; Xie H; Su Q; He S; Lei Z Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):51-61. PubMed ID: 38279482 [TBL] [Abstract][Full Text] [Related]
16. Identification and Validation of a Novel Necroptosis-Related Long Noncoding RNA Prognostic Signature for Lung Adenocarcinoma. Zeng C; Yu H; Liu X; Liu Q; Jin J Biomed Res Int; 2022; 2022():9710540. PubMed ID: 36330457 [TBL] [Abstract][Full Text] [Related]
17. Construction of a prognostic model for lung adenocarcinoma based on membrane-tension-related genes. Zhu P; Teng Z; Yang W; Zhang D; Wang B; Yang Z; Wang K; Pu J J Thorac Dis; 2023 Apr; 15(4):2098-2115. PubMed ID: 37197492 [TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma. Tian Q; Zhou Y; Zhu L; Gao H; Yang J Front Cell Dev Biol; 2021; 9():684259. PubMed ID: 34307361 [No Abstract] [Full Text] [Related]
19. Molecular subtypes of lung adenocarcinoma patients for prognosis and therapeutic response prediction with machine learning on 13 programmed cell death patterns. Wei Q; Jiang X; Miao X; Zhang Y; Chen F; Zhang P J Cancer Res Clin Oncol; 2023 Oct; 149(13):11351-11368. PubMed ID: 37378675 [TBL] [Abstract][Full Text] [Related]
20. Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma. Xu ZY; Zhao M; Chen W; Li K; Qin F; Xiang WW; Sun Y; Wei J; Yuan LQ; Li SK; Lin SH PeerJ; 2020; 8():e9530. PubMed ID: 32775050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]